SFS
RNTX

Sowell Financial Services’s Rein Therapeutics RNTX Stock Holding History

Sowell Financial Services’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-471
Closed -$10K – 2836
2021
Q1 		$10K Hold
471
– – ﹤0.01% 2338
2020
Q4 		$10K Buy
+471
New +$11.8K ﹤0.01% 2031

Other funds holding RNTX

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sowell Financial Services's RNTX Position: Q2 2021 in Review

Sowell Financial Services sold out of Rein Therapeutics (RNTX) in Q2 2021, closing a stake of 471 shares — an estimated $10K sold.

Sowell Financial Services first reported a position in RNTX in Q4 2020 and held it in 2 quarters. The position peaked at $10K in Q1 2021. 47 funds tracked by Wall St. Rank hold RNTX as of Q2 2021.

  • Sowell Financial Services reported no remaining Rein Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 471 Rein Therapeutics shares in Q2 2021, an estimated $10K.
  • Sowell Financial Services first reported a position in Rein Therapeutics in Q4 2020 and held it in 2 quarters.
  • Sowell Financial Services's Rein Therapeutics position peaked at $10K in Q1 2021.
  • 47 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.